Specific Detection of SARS-CoV-2 Neutralization Antibodies
The cPass™ SARS-CoV-2 Neutralization Antibody Test is the first and only antibody test with FDA Emergency Use Authorization (EUA) to specifically detect neutralizing antibodies.
A Positive or Negative result for the SARS-CoV-2 neutralizing antibodies indicates the presence of absence of neutralizing antibodies to the virus. Individuals should seek consultation with their HCP on this tests and guidance.
We offer an end-to-end customized testing solution inclusive of physician consultation services, specimen collection kits, coordinated logistics, and billing support.
“We are very pleased with the service Biodesix provided with the two samples for myself and our program manager. The turnaround time as well as the process, was excellent!”
Global Maritek Systems, Inc.
“This has definitely been my best experience as a customer since I moved to the US two years ago. Great job!!!!”
Carlos Garcia, CEO
"Biodesix helped Carroll College organize and test more than 1000 students on campus for COVID-19 over a one-week period. The Biodesix team was well organized, they responded to our questions promptly, and the turnaround time for testing results was as described. We are very satisfied with their work!"